Allehebi Ahmed, Kattan Khaled Al, Rujaib Mashael Al, Dayel Fouad Al, Black Edward, Mahrous Mervat, AlNassar Muath, Hussaini Hamed Al, Twairgi Abdullah Al, Abdelhafeiz Nafisa, Omair Ameen Al, Shehri Salem Al, Al-Shamsi Humaid O, Jazieh Abdul Rahman
Oncology Department King Faisal Specialist Hospital & Research Center - Jeddah, Saudi Arabia.
Dean College of Medicine, Al Faisal University, King Faisal Specialist Hospital & Research Center - Riyadh, Saudi Arabia.
Cancer Treat Res Commun. 2022;31:100538. doi: 10.1016/j.ctarc.2022.100538. Epub 2022 Feb 22.
Management of early-stage non-small cell lung cancer (ES-NSCLC) has evolved over the last few years especially in terms of work-up and the use of systemic therapy. This consensus statement was developed to present updated guidelines for the management of this disease.
Multidisciplinary team (MDT) of lung cancer experts convened to discuss a set of pertinent questions with importance relevance to the management of ES-NSCLC. ES-NSCLC includes stages I, II and resected stage III. The experts included consultants in chest imaging, thoracic surgery, radiation oncology, and medical oncology. Questions were discussed in virtual meetings and then a written manuscript with supporting evidence was drafted, reviewed, and approved by the team members.
The Consensus Statement included 9 questions addressing work-up and management of ES-NSCLC. Background information and literature review were presented for each question followed by specific recommendations to address the questions by oncology providers. The Statement was endorsed by various oncology societies in the Gulf region.
The Consensus Statement serves as a guide for thoracic MDT members in the management of ES-NSCLC. Adaptation of these to the local setting is dictated usually by available resources and expertise, however, all efforts should be excreted to provide the optimal care to all patients whenever possible.
在过去几年中，早期非小细胞肺癌（ES-NSCLC）的管理发生了演变，尤其是在检查和全身治疗的应用方面。本共识声明旨在提出针对该疾病管理的最新指南。
肺癌专家多学科团队（MDT）召开会议，讨论一系列与ES-NSCLC管理密切相关的相关问题。ES-NSCLC包括I期、II期和可切除的III期。专家包括胸部影像学、胸外科、放射肿瘤学和医学肿瘤学方面的顾问。问题在虚拟会议中进行了讨论，然后由团队成员起草、审查并批准了一份带有支持证据的书面手稿。
共识声明包括9个针对ES-NSCLC检查和管理的问题。为每个问题提供了背景信息和文献综述，随后是肿瘤学提供者针对这些问题的具体建议。该声明得到了海湾地区各肿瘤学会的认可。
共识声明为胸科MDT成员管理ES-NSCLC提供了指导。这些指南通常应根据可用资源和专业知识进行本地化调整，然而，应尽一切努力尽可能为所有患者提供最佳护理。
